Canton Strategic Holdings, Inc. (CNTN)vsModerna Inc (MRNA)
CNTN
Canton Strategic Holdings, Inc.
$2.30
+9.52%
HEALTHCARE · Cap: $167.33M
MRNA
Moderna Inc
$154.04
-2.55%
HEALTHCARE · Cap: $56.02B
Smart Verdict
WallStSmart Research — data-driven comparison
Moderna Inc generates 148840% more annual revenue ($2.23B vs $1.50M). CNTN leads profitability with a 0.0% profit margin vs -141.4%. CNTN earns a higher WallStSmart Score of 26/100 (F).
CNTN
Avoid26
out of 100
Grade: F
MRNA
Avoid21
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for CNTN.
Margin of Safety
+69.9%
Fair Value
$134.69
Current Price
$154.04
$19.35 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Large-cap with strong market position
Conservative balance sheet, low leverage
Areas to Watch
0.0% revenue growth
0.0% earnings growth
Distress zone — elevated risk
Smaller company, higher risk/reward
Trading at 9.1x book value
2.1% revenue growth
Weak financial health signals
ROE of -46.6% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : CNTN
The strongest argument for CNTN centers on Price/Book.
Bull Case : MRNA
The strongest argument for MRNA centers on Market Cap, Debt/Equity.
Bear Case : CNTN
The primary concerns for CNTN are Revenue Growth, EPS Growth, Altman Z-Score.
Bear Case : MRNA
The primary concerns for MRNA are Price/Book, Revenue Growth, Piotroski F-Score.
Key Dynamics to Monitor
CNTN profiles as a value stock while MRNA is a turnaround play — different risk/reward profiles.
CNTN carries more volatility with a beta of 1.50 — expect wider price swings.
MRNA is growing revenue faster at 2.1% — sustainability is the question.
CNTN generates stronger free cash flow (-7M), providing more financial flexibility.
Bottom Line
CNTN scores higher overall (26/100 vs 21/100). MRNA offers better value entry with a 69.9% margin of safety. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Canton Strategic Holdings, Inc.
HEALTHCARE · BIOTECHNOLOGY · USA
Canton Strategic Holdings, Inc. (CNTN) operates as a diversified investment firm focused on maximizing shareholder value through strategic acquisitions and the management of a diverse asset portfolio across multiple sectors. With an emphasis on value-driven investments and operational efficiencies, CNTN is strategically positioned to leverage emerging market opportunities and propel sustainable growth. The company’s robust approach to strategic planning and investment execution aims to deliver superior returns while effectively navigating the complexities of the financial landscape, making it an attractive option for institutional investors seeking stability and growth potential.
Moderna Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?